Genzyme Sued As Gene Therapy Pact Falls Apart
A gene therapy development company with only 13 employees has sued biotechnology giant Genzyme Corp. for allegedly misappropriating its intellectual property and depriving it of at least $5 million in benefits....To view the full article, register now.
Already a subscriber? Click here to view full article